文献速递骨软组织肉瘤与黑色素瘤

NF1相关与散发性恶性外周神经鞘瘤的临床决定因素、诊断复杂性与分子异质性:25年转诊中心队列

Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohort.
PubMed 文献 · Eur J Cancer · 2026-07-08

该回顾性队列纳入2000-2025年单中心206例MPNST患者共219次肿瘤事件,中位OS为53.6个月;NF1相关肿瘤OS显著劣于散发性(中位26.6 vs 141.0个月,p=0.012),分期、分级、NF1状态、中央位置及年龄为独立不良预后因素,活检与手术病理组织学不一致率达21.3%,放疗在高级别、局部晚期及不完全切除等特定高危情境下与生存获益相关。

要点

  • NF1相关MPNST预后显著差于散发性,中位OS 26.6 vs 141.0个月。
  • 活检与手术病理组织学不一致率21.3%,支持集中专家复核。
  • 放疗在3级、局部晚期及肉眼不完全切除者中与生存获益相关。

核心结论

  • MPNST总体预后仍差,尤其NF1相关者;疾病范围与解剖位置是主要预后驱动因素,放疗可能在特定高危情境中有益。

研究设计与样本

  • 单中心回顾性队列研究,纳入Centre Léon Bérard 2000-2025年管理的全部MPNST患者,共206例、219次肿瘤事件,采用Kaplan-Meier和多变量Cox模型(多重插补)估计OS,并对肿瘤子集行bulk RNA测序探索转录异质性。

主要发现

  • 中位OS为53.6个月;NF1相关肿瘤中位OS 26.6个月,散发性为141.0个月(p=0.012),5年限制性平均生存时间(RMST)缩短7.6个月(95%CI -13.8至-1.2;p=0.025)。
  • OS更差的独立预测因素包括更高分期(HR 2.37,p<0.001)、FNCLCC分级(HR 1.79,p<0.001)、NF1状态(HR 1.74,p=0.006)、中央位置(HR 1.75,p=0.013)和年龄较大(每10年HR 1.41,p<0.001);女性为保护因素(HR 0.46,p<0.001)。
  • 活检与手术病理组织学重大不一致发生于21.3%的病例。
  • 放疗与生存的关联呈情境依赖:3级肿瘤(HR 0.39,p<0.001)、局部晚期疾病(HR 0.32,p=0.003)及肉眼不完全切除后(HR 0.34,p=0.027)可见获益。
  • 探索性转录组分析识别出两种不依赖NF1状态的表达状态,分别以施万细胞谱系/免疫程序与增殖程序为特征。

临床怎么用

  • 对MPNST应重视分期、FNCLCC分级、NF1状态、中央位置及年龄等预后因素进行风险分层。
  • 鉴于活检与手术病理组织学不一致率达21.3%,建议集中专家复核病理以优化诊断准确性。
  • 放疗可考虑用于3级肿瘤、局部晚期疾病及肉眼不完全切除后的高危情境。

局限性

  • 回顾性单中心转诊中心队列设计,结果外推需谨慎。
  • 转录组分析为探索性、基于肿瘤子集,仅具假设生成意义。
  • 放疗与生存的关联为情境依赖性观察性结果,非随机对照证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Malignant peripheral nerve sheath tumors (MPNST) are rare, aggressive soft-tissue sarcomas frequently associated with neurofibromatosis type 1 (NF1). Prognostic factors and optimal treatment strategies remain poorly defined. METHODS: Retrospective cohort study including all MPNST patients managed at Centre Léon Bérard (2000-2025). Overall survival (OS) was estimated using Kaplan-Meier and multivariable Cox models with multiple imputation. Transcriptional heterogeneity was explored via bulk RNA sequencing in a tumor subset. RESULTS: The cohort comprised 206 patients and 219 tumor episodes. Median OS was 53.6 months. NF1-associated tumors had inferior OS compared with sporadic tumors (median OS 26.6 vs 141.0 months, p = 0.012), with a 5-year restricted mean survival time (RMST) reduction of 7.6 months (95% CI -13.8 to -1.2; p = 0.025). Independent predictors of worse OS were higher stage (HR 2.37, p < 0.001), FNCLCC grade (HR 1.79, p < 0.001), NF1 status (HR 1.74, p = 0.006), central location (HR 1.75, p = 0.013) and older age (HR 1.41 per 10 years, p < 0.001); female sex was protective (HR 0.46, p < 0.001). Major biopsy-surgical histologic discordance occurred in 21.3% of cases. Radiotherapy showed context-dependent survival associations, with benefit in grade 3 tumors (HR 0.39, p < 0.001), locally advanced disease (HR 0.32, p = 0.003) and after macroscopically incomplete resections (HR 0.34, p = 0.027). Exploratory transcriptomic analysis identified two NF1-independent expression states defined by Schwann-lineage/immune versus proliferative programs. CONCLUSIONS: Outcomes remain poor, particularly in NF1. Discordance supports centralized expert review. Disease extent and anatomical location are major prognostic drivers. Radiotherapy may be beneficial in selected high-risk contexts. The transcriptomic landscape supports hypothesis-generating biomarker development based on tumor-state biology beyond NF1 status alone.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Coste C, Brahmi M, Tirode F, et al. Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohort. Eur J Cancer. 2026. PMID: 42442319. doi:10.1016/j.ejca.2026.116930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。